These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 22294134

  • 1. Acquired dermal melanocytosis induced by psoralen plus ultraviolet A therapy.
    Nagase K, Hirashima N, Koba S, Inoue T, Misago N, Narisawa Y.
    Acta Derm Venereol; 2012 Nov; 92(6):691-2. PubMed ID: 22294134
    [No Abstract] [Full Text] [Related]

  • 2. Iatrogenic skin cancer: induction by psoralen/ultraviolet A and immunosuppression of organ transplant recipients.
    McKenna KE.
    Photodermatol Photoimmunol Photomed; 2004 Dec; 20(6):289-96. PubMed ID: 15533236
    [Abstract] [Full Text] [Related]

  • 3. Vesiculobullous eruption in a patient receiving psoralen ultraviolet A (PUVA) treatment for prurigo nodules: a case of PUVA-aggravated pemphigoid nodularis.
    Amber KT, Korta DZ, de Feraudy S, Grando SA.
    Clin Exp Dermatol; 2017 Oct; 42(7):833-835. PubMed ID: 28597976
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
    Sivanesan SP, Gattu S, Hong J, Chavez-Frazier A, Bandow GD, Malick F, Kricorian G, Koo J.
    J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of PGF2alpha on human melanocytes and regulation of the FP receptor by ultraviolet radiation.
    Scott G, Jacobs S, Leopardi S, Anthony FA, Learn D, Malaviya R, Pentland A.
    Exp Cell Res; 2005 Apr 01; 304(2):407-16. PubMed ID: 15748887
    [Abstract] [Full Text] [Related]

  • 16. Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: the role of molecular epidemiology in minimizing risks.
    Gasparro FP, Liao B, Foley PJ, Wang XM, McNiff JM.
    Environ Mol Mutagen; 1998 Apr 01; 31(2):105-12. PubMed ID: 9544188
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS, Lan CC, Wang LF, Chen GS, Wu CS, Yu HS.
    Br J Dermatol; 2007 Jan 01; 156(1):122-9. PubMed ID: 17199578
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.